Usana Health Sciences (STU:USJ) Total Liabilities: €124.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:USJ Usana Health Sciences Inc STU:USJ
67 GF Score
Price €19.20
GF Value €35.51
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Usana Health Sciences Total Liabilities?

Usana Health Sciences STU:USJ +3.78% 67 Total Liabilities is €124.7 Mil as of Mar. 2026. GuruFocus rates STU:USJ with a GF Score™ of 67/100 and a GF Value™ of €35.51 (Possible Value Trap). The stock has 7 warning signs investors should review.

Usana Health Sciences's Total Liabilities for the quarter that ended in Mar. 2026 was €124.7 Mil.

Usana Health Sciences's quarterly Total Liabilities increased from Sep. 2025 (€123.57 Mil) to Dec. 2025 (€133.77 Mil) but then declined from Dec. 2025 (€133.77 Mil) to Mar. 2026 (€124.72 Mil).

Usana Health Sciences's annual Total Liabilities increased from Dec. 2023 (€124.30 Mil) to Dec. 2024 (€154.58 Mil) but then declined from Dec. 2024 (€154.58 Mil) to Dec. 2025 (€133.77 Mil).

Usana Health Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Usana Health Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Usana Health Sciences Total Liabilities Chart

Usana Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.62 153.00 124.30 154.58 133.77

Usana Health Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.52 129.16 123.57 133.77 124.72
STU:USJ
67GF Score
Usana Health Sciences Inc STU:USJ
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Usana Health Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Usana Health Sciences's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=109.795+(0+19.8
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+4.178+0+0)
=133.8

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=634.449-500.676
=133.8

Usana Health Sciences's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=101.412+(0+18.93
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+4.374+0+0)
=124.7

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=639.206-514.49
=124.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €124.7 Mil mean?
Usana Health Sciences (STU:USJ) has a Total Liabilities of €124.7 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Usana Health Sciences and its competitors.
Is Usana Health Sciences' Total Liabilities too high?
Usana Health Sciences' current Total Liabilities is €124.7 Mil. Overall, Usana Health Sciences has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' Total Liabilities compare to NATR and ENHA?
Usana Health Sciences' Total Liabilities of €124.7 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Usana Health Sciences and its competitors. Usana Health Sciences's current Total Liabilities is €124.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (STU:USJ) is currently considered Possible Value Trap. The stock's GF Value™ is €35.51, compared to a current price of €19.20 — trading 45.9% below its estimated fair value. The current Total Liabilities is €124.7 Mil. Usana Health Sciences' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Usana Health Sciences (STU:USJ), the current Total Liabilities is €124.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Usana Health Sciences (STU:USJ) Overvalued in 2026?

Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued. The current stock price of €19.20 is trading 45.9% below its estimated GF Value™ of €35.51. GuruFocus considers Usana Health Sciences to be Possible Value Trap.

Key valuation signals for STU:USJ:

  • Total Liabilities: €124.7 Mil
  • GF Value™: €35.51 vs. price of €19.20 (45.9% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the STU:USJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Usana Health Sciences Business Description

Other Exchanges USNA:USAUSJ:Germany
Address 3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
67GF Score

Get the complete analysis for STU:USJ

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.20
Price
€35.51
GF Value